{"title":"接受体外膜氧合的患者感染动态和管理:回顾性分析。","authors":"Zhu Yuan, Shili Zhong, Qiqi Tang, Yunting Liu, Zhen Wang, Hong Xiao","doi":"10.3855/jidc.20416","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to summarize the infection situation of patients during extracorporeal membrane oxygenation (ECMO) treatment, and analyze the relevant infectious indexes before and after ECMO treatment; so as to provide clinical evidence for the control of infection after ECMO treatment.</p><p><strong>Methodology: </strong>A retrospective analysis was conducted from May 2014 to January 2024 on 66 patients treated with ECMO at the Department of Intensive Care Medicine, Daping Hospital, Army Medical University. The patients' general clinical data were collected, focusing on infection types, pathogenic bacteria, anti-infective regimens, infection markers, and coagulation function. Additionally, risk factors for infection in intensive care unit (ICU) patients undergoing ECMO treatment were analyzed.</p><p><strong>Results: </strong>Pulmonary infections were the most common among the patients in this study, and Gram-negative bacilli were the predominant pathogens. Significant reductions were observed in white blood cell count (p < 0.05, n = 57), platelet count (p < 0.05, n = 56), and fibrinogen levels (p < 0.05, n = 57) 48 hours after ECMO treatment. Of the 66 ECMO patients, 30 survived. The length of stay in the ICU was identified as an independent risk factor for adverse events following ECMO treatment.</p><p><strong>Conclusions: </strong>Controlling infection during ECMO is the cornerstone of survival and prognosis of patients. Mechanical ventilation time, continuous renal replacement therapy, central venous catheterization time, and antibiotic treatment time may be related to infection after ECMO. Early bacterial culture; and prophylactic, empirical, and targeted antimicrobials contribute to infection control.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"19 7","pages":"1039-1045"},"PeriodicalIF":1.2000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Infection dynamics and management in patients undergoing extracorporeal membrane oxygenation: a retrospective analysis.\",\"authors\":\"Zhu Yuan, Shili Zhong, Qiqi Tang, Yunting Liu, Zhen Wang, Hong Xiao\",\"doi\":\"10.3855/jidc.20416\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The aim of this study was to summarize the infection situation of patients during extracorporeal membrane oxygenation (ECMO) treatment, and analyze the relevant infectious indexes before and after ECMO treatment; so as to provide clinical evidence for the control of infection after ECMO treatment.</p><p><strong>Methodology: </strong>A retrospective analysis was conducted from May 2014 to January 2024 on 66 patients treated with ECMO at the Department of Intensive Care Medicine, Daping Hospital, Army Medical University. The patients' general clinical data were collected, focusing on infection types, pathogenic bacteria, anti-infective regimens, infection markers, and coagulation function. Additionally, risk factors for infection in intensive care unit (ICU) patients undergoing ECMO treatment were analyzed.</p><p><strong>Results: </strong>Pulmonary infections were the most common among the patients in this study, and Gram-negative bacilli were the predominant pathogens. Significant reductions were observed in white blood cell count (p < 0.05, n = 57), platelet count (p < 0.05, n = 56), and fibrinogen levels (p < 0.05, n = 57) 48 hours after ECMO treatment. Of the 66 ECMO patients, 30 survived. The length of stay in the ICU was identified as an independent risk factor for adverse events following ECMO treatment.</p><p><strong>Conclusions: </strong>Controlling infection during ECMO is the cornerstone of survival and prognosis of patients. Mechanical ventilation time, continuous renal replacement therapy, central venous catheterization time, and antibiotic treatment time may be related to infection after ECMO. Early bacterial culture; and prophylactic, empirical, and targeted antimicrobials contribute to infection control.</p>\",\"PeriodicalId\":49160,\"journal\":{\"name\":\"Journal of Infection in Developing Countries\",\"volume\":\"19 7\",\"pages\":\"1039-1045\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-07-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection in Developing Countries\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3855/jidc.20416\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.20416","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
前言:本研究旨在总结体外膜氧合(ECMO)治疗期间患者的感染情况,分析ECMO治疗前后的相关感染指标;为ECMO治疗后感染控制提供临床依据。方法:回顾性分析2014年5月至2024年1月在陆军军医大学大坪医院重症医学部接受ECMO治疗的66例患者。收集患者的一般临床资料,主要包括感染类型、致病菌、抗感染方案、感染标志物、凝血功能等。此外,还分析了重症监护病房(ICU)患者接受ECMO治疗时感染的危险因素。结果:本组患者以肺部感染为主,以革兰氏阴性杆菌为主。ECMO治疗后48小时,白细胞计数(p < 0.05, n = 57)、血小板计数(p < 0.05, n = 56)和纤维蛋白原水平(p < 0.05, n = 57)均显著降低。66例ECMO患者中,30例存活。ICU的住院时间被确定为ECMO治疗后不良事件的独立危险因素。结论:ECMO期间控制感染是患者生存和预后的基石。机械通气时间、持续肾替代治疗时间、中心静脉置管时间、抗生素治疗时间可能与ECMO后感染有关。早期细菌培养;预防性、经验性和针对性的抗微生物药物有助于感染控制。
Infection dynamics and management in patients undergoing extracorporeal membrane oxygenation: a retrospective analysis.
Introduction: The aim of this study was to summarize the infection situation of patients during extracorporeal membrane oxygenation (ECMO) treatment, and analyze the relevant infectious indexes before and after ECMO treatment; so as to provide clinical evidence for the control of infection after ECMO treatment.
Methodology: A retrospective analysis was conducted from May 2014 to January 2024 on 66 patients treated with ECMO at the Department of Intensive Care Medicine, Daping Hospital, Army Medical University. The patients' general clinical data were collected, focusing on infection types, pathogenic bacteria, anti-infective regimens, infection markers, and coagulation function. Additionally, risk factors for infection in intensive care unit (ICU) patients undergoing ECMO treatment were analyzed.
Results: Pulmonary infections were the most common among the patients in this study, and Gram-negative bacilli were the predominant pathogens. Significant reductions were observed in white blood cell count (p < 0.05, n = 57), platelet count (p < 0.05, n = 56), and fibrinogen levels (p < 0.05, n = 57) 48 hours after ECMO treatment. Of the 66 ECMO patients, 30 survived. The length of stay in the ICU was identified as an independent risk factor for adverse events following ECMO treatment.
Conclusions: Controlling infection during ECMO is the cornerstone of survival and prognosis of patients. Mechanical ventilation time, continuous renal replacement therapy, central venous catheterization time, and antibiotic treatment time may be related to infection after ECMO. Early bacterial culture; and prophylactic, empirical, and targeted antimicrobials contribute to infection control.
期刊介绍:
The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries.
JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.